You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Daniel Geiger Every time Daniel publishes a story, you’ll get an alert straight to your inbox!

Compass is a clinical-stage biotechnology company focused on developing psychedelics-based drugs for neuropsychiatric disorders. The analyst equates COMP360 to Spravato 2.0. Johnson & Johnson’s ...

The real-estate brokerage Compass announced on June 14 that it was laying off 10% of its employees. CEO Robert Reffkin addressed the layoffs in an emailed memo to staff viewed by Insider. He said the ...

Compass is not happy with the claims of Northwest MLS (NWMLS) in the MLS’s motion to dismiss the brokerage’s antitrust lawsuit against it. In a statement publicized Thursday — but as of Monday was not ...

Compass Inc. (NYSE:COMP) shares fell more than 12% while Anywhere Real Estate Inc. (NYSE:HOUS) jumped over 52% on Monday after the companies announced a $10 billion all-stock merger, including debt.

Compass cements its dominance in U.S. real estate brokerage with an all-stock acquisition of Anywhere Real Estate. The Anywhere deal more than doubles Compass' adjusted EBITDA and revenue base, ...